Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A treatment allocation procedure for sequential clinical trials

C B Begg, B Iglewicz

    Biometrics
    |March 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.

    The British journal of dermatology·2020
    Same author

    A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.

    The British journal of dermatology·2019
    Same author

    Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

    The British journal of dermatology·2017
    Same author

    Estimating the relative risk of developing melanoma in INK4A carriers.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2004
    Same author

    A regression-based method for estimating mean treatment cost in the presence of right-censoring.

    Biostatistics (Oxford, England)·2003
    Same author

    Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same journal

    Acknowledgment of Referees 2025.

    Biometrics·2026
    Same journal

    Fast penalized generalized estimating equations for large longitudinal functional datasets.

    Biometrics·2026
    Same journal

    Causally-interpretable random-effects meta-analysis.

    Biometrics·2026
    Same journal

    Statistical inference for mean function of partially observed functional time series.

    Biometrics·2026
    Same journal

    Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

    Biometrics·2026
    Same journal

    Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

    Biometrics·2026
    See all related articles

    This study introduces a dynamic treatment allocation method for clinical trials, improving upon existing procedures by balancing prognostic factors effectively. The novel approach simplifies treatment allocation decisions for better trial outcomes.

    Area of Science:

    • Clinical Trials Methodology
    • Biostatistics
    • Medical Informatics

    Background:

    • Balancing prognostic factors in clinical trials is crucial for unbiased treatment effect estimation.
    • Existing ad hoc methods for dynamic treatment allocation have limitations.

    Purpose of the Study:

    • To propose a novel dynamic treatment allocation procedure for clinical trials.
    • To balance multiple prognostic factors effectively during treatment assignment.

    Main Methods:

    • Developed a dynamic allocation procedure minimizing an approximation of the treatment effect variance.
    • Utilized linear models incorporating prognostic factors and interactions.
    • Evaluated performance via simulations against established methods.

    Related Experiment Videos

    Main Results:

    • The proposed procedure demonstrated superiority over Pocock and Simon's ad hoc methods in simulations.
    • The method is computationally feasible, even with basic calculators.
    • Successfully balanced multiple prognostic factors across treatment groups.

    Conclusions:

    • The dynamic treatment allocation procedure offers an effective and practical solution for complex clinical trials.
    • Facilitates robust treatment effect estimation by managing prognostic factor balance.
    • Addresses implementation challenges in multi-institutional settings.